Skip to main content
. 2020 Jul 28;130:110529. doi: 10.1016/j.biopha.2020.110529

Table 2.

Glucocorticoid among COVID-19 pneumonia patients (n = 86).

Medication Variable Patients (n = 86)
Duration between onset of illness and glucocorticoid initiation (d), median (Q1,Q3) 7 (6−10)
Methylprednisolone, n(%) 84/86 (97.7)
Prednisolone, n(%) 15/86 (17.4)
Duration of glucocorticoid (d), median (Q1,Q3) 6 (4−8)
Dose,glucocorticoid total equivalents (mg), median (Q1,Q3) 200 (160−280)